Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances
{{output}}
The most aggressive subtype of breast cancer is triple-negative breast cancer (TNBC), which affects about 10-15% of all breast cancer cases. TNBC is associated with a poor prognosis and drug resistance due to the lack of oestrogen, progesterone, and HER2 recep... ...
